To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AAGABTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
465 supporting clones for gene AAGAB back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BX438146 neuroblastoma AAGAB.a 1 to 817 14 to 828   tiling clone,   818/828
(98 %)
23 diff
(97.3 %id)
BX352794 Neuroblastoma Cot 10-normalized AAGAB.a 7 to 872 1 to 865   tiling clone,   865/874
(98 %)
4 diff
(99.6 %id)
FN048027 breast carcinoma AAGAB.a 1414 to 1480 1 to 67   tiling clone,   67/68
(98 %)
1 diff
(98.6 %id)
BX331334 Neuroblastoma Cot 10-normalized AAGAB.a 1787 to 2722 943 to 8   tiling clone,   936/948
(98 %)
0 diff
(100 %id)
BX438145 neuroblastoma AAGAB.a 1832 to 2726 895 to 1   tiling clone,   895/895
(100 %)
5 diff
(99.5 %id)
NM_024666.3   AAGAB.b 1 to 2842 2 to 2843 exact RefSeq, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2843/2843
(100 %)
0 diff
(100 %id)
DA688370   AAGAB.b 1 to 543 2 to 544   tiling clone, capped   543/543
(100 %)
3 diff
(99.5 %id)
TI_57215621   AAGAB.b 28 to 862 34 to 866       833/866
(96 %)
12 diff
(98.7 %id)
DA150719 amygdala AAGAB.b 49 to 624 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA644771   AAGAB.b 49 to 631 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA678605   AAGAB.b 51 to 617 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB039761 testis AAGAB.b 51 to 628 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
DA175016 amygdala AAGAB.b 52 to 611 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA307839 hippocampus AAGAB.b 52 to 632 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA602454   AAGAB.b 54 to 626 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BP342371 stomach mucosa AAGAB.b 55 to 639 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
DA477328   AAGAB.b 56 to 615 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA890346 rectum AAGAB.b 56 to 615 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
CD102526 Pooled-Skin AAGAB.b 59 to 653 1 to 599       599/733
(81 %)
17 diff
(97.7 %id)
BI464790 testis AAGAB.b 62 to 726 1 to 666       666/670
(99 %)
17 diff
(97.5 %id)
BI464791 testis AAGAB.b 62 to 867 1 to 813       811/813
(99 %)
22 diff
(97.3 %id)
BC035852 Brain, Lung, Testis, adult, pooled whole AAGAB.b 65 to 2200 1 to 2137 A127S Q128S E129R W130M C131V ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2137/2137
(100 %)
4 diff
(99.9 %id)
BM921304 pooled brain, lung, testis AAGAB.b 65 to 924 82 to 960   available from MGC,   879/1149
(76 %)
38 diff
(96.7 %id)
BG704316 brain, hippocampus AAGAB.b 69 to 653 1 to 586       586/732
(80 %)
25 diff
(96.6 %id)
DR155924 human embryonic stem cells differentiated toan early endodermal cell type AAGAB.b 70 to 860 1 to 791       791/791
(100 %)
1 diff
(99.9 %id)
BX360665 Placenta Cot 25-normalized AAGAB.b 71 to 977 1 to 905       905/977
(92 %)
9 diff
(99.1 %id)
CV574302 cornea, eye AAGAB.b 71 to 685 1 to 615       615/615
(100 %)
0 diff
(100 %id)
BP354992   AAGAB.b 71 to 383 283 to 596       314/596
(52 %)
9 diff
(98.5 %id)
DA395117 thalamus AAGAB.b 73 to 667 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
BJ991601 hepatoblastoma AAGAB.b 73 to 478 1 to 406       406/406
(100 %)
4 diff
(99.1 %id)
DA022124   AAGAB.b 76 to 641 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
BQ646684 hepatocellular carcinoma, cell line, Liver AAGAB.b 76 to 924 1 to 860       860/892
(96 %)
18 diff
(98.0 %id)
TI_57163313   AAGAB.b 76 to 800 29 to 753       725/753
(96 %)
8 diff
(99.0 %id)
BC047026 Uterus, leiomyosarcoma AAGAB.b 77 to 2200 1 to 2124 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2124/2124
(100 %)
1 diff
(100.0 %id)
DA042720 bladder AAGAB.b 78 to 533 2 to 461   capped   460/460
(100 %)
5 diff
(99.0 %id)
DA066022 cerebellum AAGAB.b 78 to 640 2 to 564   capped   563/565
(99 %)
1 diff
(99.9 %id)
DA151590 amygdala AAGAB.b 78 to 526 2 to 450   capped   449/450
(99 %)
5 diff
(98.9 %id)
DA379760 thalamus AAGAB.b 78 to 722 2 to 645   capped   644/644
(100 %)
1 diff
(99.9 %id)
DA382071 thalamus AAGAB.b 78 to 634 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA421479 cervix AAGAB.b 78 to 645 2 to 572   capped   571/571
(100 %)
5 diff
(99.2 %id)
CN259735 embryonic stem cells, DMSO-treated H9 cellline AAGAB.b 78 to 717 1 to 640       640/640
(100 %)
1 diff
(99.9 %id)
DA443046 tongue, tumor tissue AAGAB.b 78 to 633 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB465329 hippocampus AAGAB.b 78 to 497 1 to 420       420/420
(100 %)
4 diff
(99.1 %id)
DA575333   AAGAB.b 78 to 638 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
DA593731 lung AAGAB.b 78 to 645 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BM005973 hepatocellular carcinoma, cell line, Liver AAGAB.b 78 to 635 1 to 558       558/574
(97 %)
4 diff
(99.4 %id)
BM800355 leiomyosarcoma, uterus AAGAB.b 78 to 923 1 to 851       851/1112
(76 %)
11 diff
(99.1 %id)
BM545772 ovary (pool of 3) AAGAB.b 78 to 726 130 to 785       656/1261
(52 %)
19 diff
(98.5 %id)
DA612349   AAGAB.b 78 to 648 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA660820   AAGAB.b 78 to 555 2 to 481   capped   480/486
(98 %)
5 diff
(99.0 %id)
DA699484   AAGAB.b 78 to 606 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA707145   AAGAB.b 78 to 650 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA904483   AAGAB.b 78 to 551 2 to 476   capped   475/475
(100 %)
1 diff
(99.8 %id)
DA929564 small intestine AAGAB.b 78 to 641 2 to 567   capped   566/566
(100 %)
4 diff
(99.3 %id)
DB124800 thymus AAGAB.b 78 to 529 2 to 453   capped   452/452
(100 %)
0 diff
(100 %id)
TI_59385924   AAGAB.b 79 to 635 65 to 621       557/573
(97 %)
3 diff
(99.5 %id)
BP283248 bone marrow AAGAB.b 79 to 665 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BP283283 bone marrow AAGAB.b 79 to 652 1 to 574       574/583
(98 %)
10 diff
(98.3 %id)
DA753923   AAGAB.b 79 to 626 2 to 550   capped   549/549
(100 %)
4 diff
(99.3 %id)
DA241690 brain AAGAB.b 80 to 662 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DA265048 caudate nucleus AAGAB.b 80 to 666 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
DA310910 hippocampus AAGAB.b 80 to 649 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA391585 thalamus AAGAB.b 80 to 652 2 to 575   capped   574/584
(98 %)
10 diff
(98.3 %id)
DA538396 Kidney AAGAB.b 80 to 674 2 to 597   capped   596/596
(100 %)
2 diff
(99.7 %id)
DA580074   AAGAB.b 80 to 642 2 to 565   capped   564/570
(98 %)
3 diff
(99.5 %id)
DA601359   AAGAB.b 80 to 642 2 to 565   capped   564/564
(100 %)
1 diff
(99.9 %id)
BM928638 hepatocellular carcinoma, cell line, Liver AAGAB.b 80 to 983 1 to 902       902/1029
(87 %)
16 diff
(98.5 %id)
BQ651660 hepatocellular carcinoma, cell line, Liver AAGAB.b 80 to 925 1 to 858       858/901
(95 %)
19 diff
(97.9 %id)
BQ650286 hepatocellular carcinoma, cell line, Liver AAGAB.b 80 to 995 1 to 926       924/967
(95 %)
25 diff
(97.5 %id)
BQ645951 hepatocellular carcinoma, cell line, Liver AAGAB.b 80 to 726 1 to 654       654/936
(69 %)
13 diff
(98.7 %id)
BQ654101 hepatocellular carcinoma, cell line, Liver AAGAB.b 80 to 974 1 to 896       894/922
(96 %)
19 diff
(98.0 %id)
DR762295 embryonic stem AAGAB.b 80 to 895 1 to 816       816/816
(100 %)
0 diff
(100 %id)
DA619654   AAGAB.b 80 to 679 2 to 602   capped   601/601
(100 %)
2 diff
(99.7 %id)
DA632363 Kidney AAGAB.b 80 to 644 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA719493   AAGAB.b 80 to 658 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DA926151 small intestine AAGAB.b 80 to 641 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA945198 Spleen AAGAB.b 80 to 635 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB004654 breast, tumor tissue AAGAB.b 80 to 643 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BP357531 mammary gland AAGAB.b 80 to 662 1 to 583       583/583
(100 %)
0 diff
(100 %id)
CD673183 eye, Iris AAGAB.b 81 to 579 1 to 499       499/499
(100 %)
1 diff
(99.8 %id)
BE513238 adenocarcinoma cell line, colon AAGAB.b 81 to 820 45 to 794       746/984
(75 %)
26 diff
(97.4 %id)
BF670331 muscle (skeletal) AAGAB.b 81 to 722 1 to 641       641/847
(75 %)
21 diff
(97.6 %id)
BQ896238 brain, neuroblastoma, cell line AAGAB.b 81 to 990 25 to 934       910/934
(97 %)
12 diff
(98.8 %id)
DB110938 thymus AAGAB.b 81 to 658 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA147799 amygdala AAGAB.b 82 to 655 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
BP271583   AAGAB.b 82 to 714 1 to 633       633/633
(100 %)
11 diff
(98.3 %id)
BP327891 prostata AAGAB.b 82 to 663 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DA483260 brain AAGAB.b 83 to 776 2 to 697   capped   696/696
(100 %)
6 diff
(99.2 %id)
DA607120   AAGAB.b 83 to 634 2 to 553   capped   552/553
(99 %)
1 diff
(99.9 %id)
DA703876   AAGAB.b 83 to 626 2 to 546   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA814291   AAGAB.b 83 to 641 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DB012281 esophageal, tumor tissue AAGAB.b 83 to 580 2 to 499   capped   498/498
(100 %)
0 diff
(100 %id)
BP209939 cerebellum AAGAB.b 84 to 665 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN259733 embryonic stem cells, cell lines H1, H7, andH9 AAGAB.b 84 to 814 1 to 734       734/734
(100 %)
10 diff
(98.7 %id)
BF240889 bone marrow, from acute myelogenous leukemia AAGAB.b 84 to 586 1 to 509       507/804
(63 %)
14 diff
(98.3 %id)
BI838177 pooled pancreas and spleen AAGAB.b 84 to 800 1 to 717       717/717
(100 %)
3 diff
(99.6 %id)
CX867271 embryonic stem AAGAB.b 84 to 874 1 to 791     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 791/791
(100 %)
0 diff
(100 %id)
DA342447 substantia nigra AAGAB.b 85 to 654 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
CD672100 eye, Iris AAGAB.b 85 to 530 1 to 446     Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 446/446
(100 %)
2 diff
(99.6 %id)
DA563278 heart AAGAB.b 85 to 550 2 to 469   capped   468/468
(100 %)
3 diff
(99.4 %id)
BP326864 prostata AAGAB.b 85 to 669 1 to 585       585/585
(100 %)
0 diff
(100 %id)
DB048124 testis AAGAB.b 85 to 641 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DA052873   AAGAB.b 86 to 647 2 to 564   capped   563/563
(100 %)
3 diff
(99.5 %id)
DA146701 amygdala AAGAB.b 86 to 664 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA429894 colon AAGAB.b 86 to 630 2 to 547   capped   546/546
(100 %)
2 diff
(99.7 %id)
DA431999 colon AAGAB.b 86 to 664 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DA538646 Kidney AAGAB.b 86 to 656 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
DA575500   AAGAB.b 86 to 634 2 to 552   capped   551/551
(100 %)
3 diff
(99.5 %id)
DA607205   AAGAB.b 86 to 634 2 to 550   capped   549/551
(99 %)
2 diff
(99.7 %id)
TI_57240311   AAGAB.b 86 to 924 29 to 872       844/907
(93 %)
23 diff
(97.5 %id)
DA644124   AAGAB.b 86 to 659 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DA682892   AAGAB.b 86 to 889 2 to 805   capped   804/804
(100 %)
1 diff
(99.9 %id)
DA710426   AAGAB.b 86 to 638 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA738397   AAGAB.b 86 to 948 2 to 862   capped   861/861
(100 %)
6 diff
(99.4 %id)
DA909546   AAGAB.b 86 to 662 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB248756 uterus AAGAB.b 86 to 626 2 to 544   capped   543/543
(100 %)
2 diff
(99.7 %id)
BF725842 eye, Iris AAGAB.b 87 to 530 1 to 444       444/444
(100 %)
1 diff
(99.8 %id)
BI838891 pooled pancreas and spleen AAGAB.b 87 to 645 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
TI_57165909   AAGAB.b 87 to 645 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
DN989854 brain, whole brain AAGAB.b 87 to 854 4 to 772       769/772
(99 %)
16 diff
(98.0 %id)
BC058886 Uterus, leiomyosarcoma AAGAB.b 88 to 2200 11 to 2123 exact available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2113/2113
(100 %)
1 diff
(100.0 %id)
CD709332 normal nasopharynx AAGAB.b 88 to 641 23 to 576       554/576
(96 %)
6 diff
(99.0 %id)
BX414647 thymus AAGAB.b 88 to 550 1 to 463       463/577
(80 %)
3 diff
(99.5 %id)
BI553425 brain, hippocampus AAGAB.b 88 to 901 6 to 824       819/824
(99 %)
20 diff
(97.6 %id)
BU902320 leiomyosarcoma, uterus AAGAB.b 88 to 1158 10 to 1081 E263X K268S L269*     1072/1182
(90 %)
18 diff
(98.5 %id)
TI_57168147   AAGAB.b 88 to 861 17 to 790       774/792
(97 %)
9 diff
(98.9 %id)
TI_44170262   AAGAB.b 88 to 901 91 to 909       819/909
(90 %)
20 diff
(97.8 %id)
TI_59395019   AAGAB.b 88 to 636 117 to 661       545/549
(99 %)
17 diff
(97.0 %id)
BM006357 ductal carcinoma, cell line, Pancreas AAGAB.b 89 to 636 1 to 544       544/548
(99 %)
17 diff
(96.9 %id)
AL136715 Kidney AAGAB.b 90 to 2842 1 to 2753 I26T Q88R C131S I132L L265P ... tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2753/2753
(100 %)
11 diff
(99.7 %id)
BI826570 brain, medulla AAGAB.b 90 to 962 1 to 865       865/876
(98 %)
14 diff
(98.5 %id)
TI_57174182   AAGAB.b 90 to 962 30 to 894       865/905
(95 %)
19 diff
(98.0 %id)
DB467368 hippocampus AAGAB.b 91 to 539 1 to 448       448/448
(100 %)
7 diff
(98.5 %id)
DR762371 embryonic stem AAGAB.b 91 to 871 1 to 781       781/781
(100 %)
0 diff
(100 %id)
BX335661 Placenta Cot 25-normalized AAGAB.b 92 to 1120 1 to 1019 H204X L309F S310X S311L D312M ... fully sequenced,   1019/1019
(100 %)
13 diff
(98.8 %id)
BI834717 pooled pancreas and spleen AAGAB.b 92 to 861 1 to 770       770/772
(99 %)
3 diff
(99.7 %id)
BQ877979 ductal carcinoma, cell line, Pancreas AAGAB.b 92 to 923 1 to 835       835/919
(90 %)
14 diff
(98.5 %id)
DA567092 heart AAGAB.b 93 to 652 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BG328460 adenocarcinoma cell line, colon AAGAB.b 93 to 819 1 to 724       724/901
(80 %)
10 diff
(98.9 %id)
CA495400   AAGAB.b 93 to 965 1 to 880       880/881
(99 %)
9 diff
(99.0 %id)
DA017387 adrenal gland AAGAB.b 94 to 647 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BI913349 brain AAGAB.b 94 to 924 1 to 837       837/872
(95 %)
18 diff
(98.0 %id)
DB246396 uterus, tumor tissue AAGAB.b 94 to 666 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
BF964199 nervous_normal AAGAB.b 95 to 553 13 to 473       461/473
(97 %)
6 diff
(98.8 %id)
CD687297 normal nasopharynx AAGAB.b 95 to 643 25 to 573       549/573
(95 %)
6 diff
(99.0 %id)
DB448407 testis AAGAB.b 95 to 516 1 to 421       421/421
(100 %)
4 diff
(99.1 %id)
BE882300 leiomyosarcoma, uterus AAGAB.b 95 to 805 1 to 708       708/713
(99 %)
17 diff
(97.7 %id)
DB172726 kidney, tumor tissue AAGAB.b 95 to 696 2 to 604   capped   603/603
(100 %)
1 diff
(99.9 %id)
AK021568 whole embryo, mainly head AAGAB.b 96 to 2200 1 to 2106 I132L available from FLJ,   2106/2106
(100 %)
6 diff
(99.8 %id)
DN914198   AAGAB.b 96 to 791 1 to 693       693/694
(99 %)
10 diff
(98.6 %id)
DT216666 brain AAGAB.b 96 to 678 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
BI464786 testis AAGAB.b 96 to 864 1 to 761       761/762
(99 %)
23 diff
(97.0 %id)
BP353199   AAGAB.b 96 to 703 1 to 608       608/608
(100 %)
1 diff
(99.9 %id)
DB184282 liver, tumor tissue AAGAB.b 96 to 678 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA047447   AAGAB.b 97 to 662 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA309675 hippocampus AAGAB.b 97 to 528 2 to 433   capped   432/432
(100 %)
1 diff
(99.8 %id)
AU117771 whole embryo, mainly head AAGAB.b 97 to 927 2 to 831   capped   830/844
(98 %)
7 diff
(99.2 %id)
DA587428 lung AAGAB.b 97 to 688 2 to 593   capped   592/592
(100 %)
0 diff
(100 %id)
DA636348 Kidney AAGAB.b 97 to 669 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA672032   AAGAB.b 97 to 670 2 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DA711006   AAGAB.b 97 to 644 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DA915097   AAGAB.b 97 to 654 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA968472 stomach AAGAB.b 97 to 647 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB010375 colon, tumor tissue AAGAB.b 97 to 626 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
DB184948 liver, tumor tissue AAGAB.b 97 to 669 2 to 574   capped   573/573
(100 %)
3 diff
(99.5 %id)
AA331876 Embryo, 8 weeks AAGAB.b 98 to 425 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
AA333060 Embryo, 8 weeks AAGAB.b 98 to 417 1 to 321       321/321
(100 %)
4 diff
(98.8 %id)
AA333603 Embryo, 8 weeks AAGAB.b 98 to 492 1 to 396       396/399
(99 %)
8 diff
(98.0 %id)
AA332406 Embryo, 8 weeks AAGAB.b 99 to 512 1 to 421       421/423
(99 %)
12 diff
(97.2 %id)
AW962654   AAGAB.b 99 to 722 1 to 620       620/624
(99 %)
16 diff
(97.5 %id)
BE885279 leiomyosarcoma, uterus AAGAB.b 100 to 780 1 to 681       681/938
(72 %)
16 diff
(98.3 %id)
BF671464 muscle (skeletal) AAGAB.b 100 to 807 1 to 702       702/712
(98 %)
22 diff
(97.0 %id)
DA048342   AAGAB.b 101 to 494 8 to 401   capped   394/400
(98 %)
6 diff
(98.5 %id)
BP213251 cerebrum AAGAB.b 101 to 664 1 to 564       564/564
(100 %)
0 diff
(100 %id)
DB018958 esophageal, tumor tissue AAGAB.b 101 to 580 2 to 481   capped   480/480
(100 %)
0 diff
(100 %id)
DA021392   AAGAB.b 102 to 626 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA060681 cerebellum AAGAB.b 102 to 659 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DA152096 amygdala AAGAB.b 102 to 669 2 to 569   capped   568/568
(100 %)
2 diff
(99.7 %id)
DA452720 tongue, tumor tissue AAGAB.b 102 to 689 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA709378   AAGAB.b 102 to 668 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DB060153 testis AAGAB.b 102 to 629 2 to 529   capped   528/528
(100 %)
2 diff
(99.7 %id)
AA333418 Embryo, 8 weeks AAGAB.b 103 to 429 5 to 333       329/334
(98 %)
9 diff
(97.4 %id)
DB443879 testis AAGAB.b 104 to 552 1 to 447       447/447
(100 %)
3 diff
(99.4 %id)
CR533540   AAGAB.b 105 to 1167 1 to 1063 I26T V77A Q88R C131S I132L ...     1063/1063
(100 %)
7 diff
(99.4 %id)
EL734852 mixed AAGAB.b 105 to 773 1 to 669       669/669
(100 %)
0 diff
(100 %id)
TI_1948215474   AAGAB.b 105 to 701 122 to 718   fully sequenced,   597/718
(83 %)
6 diff
(99.2 %id)
TI_1948215636   AAGAB.b 105 to 923 128 to 951       824/1402
(58 %)
21 diff
(98.6 %id)
TI_1948215803   AAGAB.b 105 to 670 125 to 690   fully sequenced,   566/690
(82 %)
7 diff
(99.0 %id)
TI_1948215955   AAGAB.b 105 to 670 125 to 690   fully sequenced,   566/690
(82 %)
6 diff
(99.2 %id)
CN259731 embryonic stem cells, DMSO-treated H9 cellline AAGAB.b 106 to 730 1 to 625       625/625
(100 %)
1 diff
(99.9 %id)
BE615469 adenocarcinoma, Pancreas AAGAB.b 106 to 804 1 to 701       701/701
(100 %)
10 diff
(98.6 %id)
BG478490 melanotic melanoma, skin AAGAB.b 106 to 864 1 to 765       763/766
(99 %)
16 diff
(98.0 %id)
BG478718 melanotic melanoma, skin AAGAB.b 106 to 917 1 to 817       817/828
(98 %)
11 diff
(98.7 %id)
DB040164 testis AAGAB.b 106 to 677 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
BE614857 adenocarcinoma, Pancreas AAGAB.b 107 to 882 1 to 770       770/771
(99 %)
20 diff
(97.5 %id)
BE615726 adenocarcinoma, Pancreas AAGAB.b 107 to 922 1 to 813       813/816
(99 %)
17 diff
(98.0 %id)
BM802041 duodenal adenocarcinoma, cell line, small intestine AAGAB.b 107 to 1160 12 to 1072       1061/1132
(93 %)
28 diff
(97.6 %id)
BM564924 eye, retinoblastoma AAGAB.b 108 to 983 1 to 887       885/1046
(84 %)
27 diff
(97.5 %id)
CN259737 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells AAGAB.b 109 to 819 1 to 712       712/720
(98 %)
2 diff
(99.8 %id)
BM466314 eye, retinoblastoma AAGAB.b 115 to 330 1 to 216       216/216
(100 %)
0 diff
(100 %id)
DA813006   AAGAB.b 115 to 941 2 to 826   capped   825/832
(99 %)
6 diff
(99.3 %id)
BU158695 large cell carcinoma, lung AAGAB.b 117 to 973 1 to 860       860/879
(97 %)
19 diff
(97.9 %id)
CN259734 embryonic stem cells, DMSO-treated H9 cellline AAGAB.b 126 to 774 9 to 657       649/657
(98 %)
8 diff
(98.8 %id)
CN259736 embryonic stem cells, cell lines H1, H7, andH9 AAGAB.b 134 to 878 1 to 745       745/745
(100 %)
4 diff
(99.5 %id)
CN259730 embryonic stem cells, DMSO-treated H9 cellline AAGAB.b 142 to 697 1 to 557       557/557
(100 %)
2 diff
(99.7 %id)
BQ428435 leiomyosarcoma, uterus AAGAB.b 158 to 1014 1 to 860       860/861
(99 %)
7 diff
(99.2 %id)
DA158016 amygdala AAGAB.b 177 to 737 16 to 576   capped   562/575
(97 %)
6 diff
(99.0 %id)
AW245875 lung, small cell carcinoma AAGAB.b 196 to 813 19 to 636     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 618/636
(97 %)
6 diff
(99.1 %id)
DA198621 brain AAGAB.b 204 to 772 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
CB267775 adipose AAGAB.b 211 to 819 1 to 608       608/618
(98 %)
2 diff
(99.7 %id)
CN259729 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells AAGAB.b 223 to 904 1 to 683       683/683
(100 %)
1 diff
(99.9 %id)
BQ425900 leiomyosarcoma, uterus AAGAB.b 224 to 973 1 to 750       748/883
(84 %)
8 diff
(99.1 %id)
DB018459 esophageal, tumor tissue AAGAB.b 249 to 817 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
BG506459 lung AAGAB.b 300 to 639 233 to 572       340/572
(59 %)
10 diff
(98.3 %id)
BQ214285 embryonal carcinoma, cell line, testis AAGAB.b 300 to 1196 1 to 907       907/908
(99 %)
17 diff
(98.2 %id)
BE870614 adenocarcinoma, colon AAGAB.b 314 to 917 1 to 605       605/943
(64 %)
11 diff
(98.9 %id)
BX405323 T cells (Jurkat cell line) AAGAB.b 336 to 1317 1 to 977       977/987
(98 %)
20 diff
(98.0 %id)
AV750680 Pituitary AAGAB.b 365 to 697 329 to 1     Submitted on the opposite strand 329/335
(98 %)
8 diff
(97.7 %id)
BX394397 Neuroblastoma Cot 25-normalized AAGAB.b 423 to 1386 1 to 963       963/963
(100 %)
5 diff
(99.5 %id)
BX372402   AAGAB.b 465 to 1367 900 to 1       900/900
(100 %)
8 diff
(99.2 %id)
BC001975 Cervix, carcinoma AAGAB.b 479 to 2681 1 to 2204   available from MGC, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 2204/2204
(100 %)
3 diff
(99.9 %id)
FN161795 breast carcinoma AAGAB.b 496 to 597 1 to 102       102/102
(100 %)
0 diff
(100 %id)
BF334075 colon AAGAB.b 511 to 739 1 to 229       229/229
(100 %)
0 diff
(100 %id)
BF334079 colon AAGAB.b 511 to 739 1 to 229       229/229
(100 %)
1 diff
(99.6 %id)
BE143310 head_neck AAGAB.b 515 to 809 1 to 298       298/298
(100 %)
11 diff
(96.4 %id)
BF529208 anaplastic oligodendroglioma with 1p/19qloss, brain AAGAB.b 519 to 1127 1 to 614       614/863
(71 %)
44 diff
(95.0 %id)
R12611 whole brain AAGAB.b 520 to 925 1 to 411       411/457
(89 %)
15 diff
(96.8 %id)
R19623 whole brain AAGAB.b 520 to 876 1 to 362       362/447
(80 %)
13 diff
(97.1 %id)
H23065 whole brain AAGAB.b 520 to 915 1 to 398       398/398
(100 %)
4 diff
(99.0 %id)
DA773886 brain AAGAB.b 522 to 1096 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BM799340 Ascites, stomach AAGAB.b 564 to 955 1 to 392       392/392
(100 %)
2 diff
(99.5 %id)
BE149970 head_neck AAGAB.b 569 to 992 1 to 423       423/437
(96 %)
15 diff
(96.6 %id)
BF932312 nervous_tumor AAGAB.b 569 to 735 1 to 167       167/167
(100 %)
4 diff
(97.7 %id)
DA745493   AAGAB.b 579 to 1148 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BP331402 rectum AAGAB.b 580 to 1160 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
TI_1948215804   AAGAB.b 609 to 1051 563 to 121   fully sequenced,   443/563
(78 %)
0 diff
(100 %id)
TI_1948215956   AAGAB.b 609 to 1051 566 to 124   fully sequenced,   443/566
(78 %)
0 diff
(100 %id)
CX866999.
matches multiple genes
embryonic stem AAGAB.b 639 to 807 617 to 785   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene SMAD3 170/785
(21 %)
6 diff
(99.3 %id)
BP295769   AAGAB.b 639 to 1206 17 to 584       573/584
(98 %)
7 diff
(98.9 %id)
BQ188920 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.b 643 to 928 1 to 286   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 286/286
(100 %)
9 diff
(96.9 %id)
TI_1948215475   AAGAB.b 671 to 1051 505 to 125   fully sequenced,   381/505
(75 %)
0 diff
(100 %id)
AA984055 schizophrenic brain S-11 frontal lobe AAGAB.b 748 to 939 1 to 192     Submitted on the opposite strand 192/192
(100 %)
1 diff
(99.5 %id)
CV573904 cornea, eye AAGAB.b 750 to 1048 1 to 299       299/299
(100 %)
6 diff
(98.0 %id)
AI905472 breast AAGAB.b 757 to 1213 468 to 13       456/476
(95 %)
4 diff
(99.2 %id)
AI905524 breast AAGAB.b 757 to 1213 9 to 464       456/465
(98 %)
13 diff
(97.3 %id)
AI905535 breast AAGAB.b 757 to 1213 9 to 464       456/465
(98 %)
12 diff
(97.5 %id)
AI905536 breast AAGAB.b 757 to 1213 9 to 464       456/465
(98 %)
12 diff
(97.5 %id)
CR620129 Placenta Cot 25-normalized AAGAB.b 760 to 2169 1 to 1410       1410/1410
(100 %)
0 diff
(100 %id)
BX378148 Placenta Cot 25-normalized AAGAB.b 760 to 1683 1 to 915   fully sequenced,   915/915
(100 %)
1 diff
(99.9 %id)
AI905397 breast AAGAB.b 768 to 1200 475 to 43       433/476
(90 %)
0 diff
(100 %id)
CV570447 cornea, eye AAGAB.b 777 to 1385 1 to 610       610/610
(100 %)
2 diff
(99.7 %id)
CK300288 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.b 789 to 928 140 to 2   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 139/140
(99 %)
0 diff
(100 %id)
BU166464 bone marrow, from acute myelogenous leukemia AAGAB.b 817 to 1401 1 to 594       594/837
(70 %)
41 diff
(95.2 %id)
BP421755 small intestine AAGAB.b 846 to 1363 1 to 519     Submitted on the opposite strand 519/519
(100 %)
6 diff
(98.9 %id)
FN051208 breast carcinoma AAGAB.b 870 to 953 1 to 84       84/85
(98 %)
1 diff
(98.9 %id)
BF038801 adenocarcinoma, ovary AAGAB.b 882 to 1595 1 to 710       710/710
(100 %)
17 diff
(97.7 %id)
BU558018 adenocarcinoma, cell line, breast AAGAB.b 927 to 1172 8 to 253       244/253
(96 %)
6 diff
(97.7 %id)
FN137775 breast carcinoma AAGAB.b 967 to 1060 1 to 96       94/97
(96 %)
1 diff
(99.0 %id)
BX335660 Placenta Cot 25-normalized AAGAB.b 1090 to 2166 1067 to 1   fully sequenced,   1067/1067
(100 %)
18 diff
(98.4 %id)
BX360664 Placenta Cot 25-normalized AAGAB.b 1116 to 2172 1044 to 1       1044/1048
(99 %)
17 diff
(98.4 %id)
DB370979   AAGAB.b 1454 to 2200 748 to 1       748/751
(99 %)
8 diff
(99.0 %id)
CX866914.
matches multiple genes
embryonic stem AAGAB.b 1591 to 2214 649 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base), also hits gene SMAD3 624/624
(100 %)
3 diff
(99.6 %id)
CX867192 embryonic stem AAGAB.b 1639 to 2200 592 to 30   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 563/563
(100 %)
5 diff
(99.2 %id)
BX378147 Placenta Cot 25-normalized AAGAB.b 1653 to 2168 500 to 1   fully sequenced,   500/500
(100 %)
10 diff
(98.0 %id)
AW245617 lung, small cell carcinoma AAGAB.b 1661 to 2200 550 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 540/540
(100 %)
1 diff
(99.9 %id)
AU144515 whole embryo, mainly head AAGAB.b 1668 to 2200 534 to 1       534/542
(98 %)
13 diff
(97.7 %id)
DB322702   AAGAB.b 1688 to 2200 514 to 1       514/514
(100 %)
15 diff
(97.1 %id)
BJ991602 hepatoblastoma AAGAB.b 1702 to 2165 464 to 1       464/464
(100 %)
0 diff
(100 %id)
BX375579 Neuroblastoma Cot 25-normalized AAGAB.b 1743 to 2185 443 to 1       443/498
(88 %)
28 diff
(94.4 %id)
H24343 whole brain AAGAB.b 1805 to 2203 415 to 9       407/419
(97 %)
0 diff
(100 %id)
R20517 whole brain AAGAB.b 1847 to 2202 379 to 11       369/382
(96 %)
0 diff
(100 %id)
BX405322 T cells (Jurkat cell line) AAGAB.b 2271 to 2828 557 to 1       557/562
(99 %)
7 diff
(98.8 %id)
CD672099 eye, Iris AAGAB.b 2582 to 2842 277 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 261/261
(100 %)
0 diff
(100 %id)
DA418448 thalamus AAGAB.c 1 to 533 2 to 534   tiling clone, capped   533/533
(100 %)
2 diff
(99.7 %id)
DA578860   AAGAB.c 3 to 568 2 to 567   capped   566/566
(100 %)
0 diff
(100 %id)
DA736390   AAGAB.c 4 to 614 2 to 612   capped   611/611
(100 %)
4 diff
(99.4 %id)
DA307821 hippocampus AAGAB.c 13 to 519 2 to 510   capped   509/509
(100 %)
3 diff
(99.5 %id)
DB179782 kidney, tumor tissue AAGAB.c 14 to 560 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA582879 lung AAGAB.c 15 to 620 2 to 607   capped   606/606
(100 %)
2 diff
(99.7 %id)
DA692810   AAGAB.c 15 to 579 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA720878   AAGAB.c 17 to 589 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA699124   AAGAB.c 20 to 544 2 to 526   capped   525/525
(100 %)
0 diff
(100 %id)
DA790105 brain AAGAB.c 47 to 634 2 to 589   capped   588/588
(100 %)
1 diff
(99.9 %id)
CD694643 normal nasopharynx AAGAB.c 342 to 808 23 to 489   tiling clone,   467/495
(94 %)
8 diff
(98.4 %id)
DB368859   AAGAB.c 1897 to 2453 548 to 1   tiling clone,   548/557
(98 %)
24 diff
(95.7 %id)
DB323584   AAGAB.c 1920 to 2453 534 to 1   tiling clone,   534/534
(100 %)
1 diff
(99.9 %id)
CR614587 B cells (Ramos cell line) Cot 25-normalized AAGAB.d 1 to 2251 1 to 2251   tiling clone,   2251/2251
(100 %)
0 diff
(100 %id)
DB104297 thymus AAGAB.d 23 to 580 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA160293 amygdala AAGAB.d 26 to 589 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
DA646146 mammary gland AAGAB.d 26 to 747 2 to 723   capped   722/729
(99 %)
2 diff
(99.8 %id)
DA886819   AAGAB.d 26 to 573 2 to 549   capped   548/548
(100 %)
2 diff
(99.7 %id)
ES309107 occipital hair of pubic hypotrichosispatient, skin AAGAB.d 30 to 524 1 to 494       494/497
(99 %)
4 diff
(99.2 %id)
CX872144 embryonic stem AAGAB.d 33 to 786 1 to 754       754/754
(100 %)
2 diff
(99.8 %id)
BP358449 mammary gland AAGAB.d 33 to 615 1 to 581       581/581
(100 %)
9 diff
(98.5 %id)
DA305826 hippocampus AAGAB.d 34 to 595 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
BI596757 brain, hypothalamus AAGAB.d 34 to 855 1 to 825       825/825
(100 %)
13 diff
(98.5 %id)
DA689543   AAGAB.d 37 to 584 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
DB002394 breast, tumor tissue AAGAB.d 37 to 579 2 to 545   capped   544/544
(100 %)
2 diff
(99.7 %id)
TI_45208742   AAGAB.d 39 to 855 174 to 993       820/993
(82 %)
14 diff
(98.6 %id)
DA182573 amygdala AAGAB.d 42 to 611 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DA968782 stomach AAGAB.d 42 to 587 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
BX385433   AAGAB.d 44 to 1013 43 to 1013       971/1053
(92 %)
9 diff
(99.2 %id)
CN259732 embryonic stem cells, cell lines H1, H7, andH9 AAGAB.d 66 to 373 1 to 308       308/308
(100 %)
2 diff
(99.4 %id)
DA048043   AAGAB.d 79 to 608 2 to 531   capped   530/530
(100 %)
1 diff
(99.9 %id)
BF312145 brain, neuroblastoma AAGAB.d 107 to 886 1 to 781       781/895
(87 %)
21 diff
(97.7 %id)
BI195540 brain, neuroblastoma AAGAB.d 107 to 770 1 to 665       665/666
(99 %)
5 diff
(99.3 %id)
BF892082 marrow AAGAB.d 200 to 534 14 to 346       333/356
(93 %)
13 diff
(96.4 %id)
BF892445 marrow AAGAB.d 200 to 539 346 to 7     Submitted on the opposite strand 340/351
(96 %)
8 diff
(97.8 %id)
BF892741 marrow AAGAB.d 200 to 534 6 to 339       334/349
(95 %)
9 diff
(97.5 %id)
BG252279 adenocarcinoma, cell line, Liver AAGAB.d 1063 to 1809 1 to 751       751/792
(94 %)
24 diff
(97.0 %id)
AV684164 hepatocellular carcinoma AAGAB.d 1067 to 1676 1 to 606       606/609
(99 %)
4 diff
(99.4 %id)
W77976 heart AAGAB.d 1083 to 1540 1 to 458       458/462
(99 %)
1 diff
(99.8 %id)
CD678500 eye, Trabecular meshwork AAGAB.d 1087 to 1727 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
CD107861 brain, Pituitary AAGAB.d 1087 to 1957 26 to 902       877/905
(96 %)
10 diff
(98.9 %id)
BX095558 liver and spleen AAGAB.d 1121 to 1800 56 to 735       680/735
(92 %)
6 diff
(99.2 %id)
CR748038 liver and spleen AAGAB.d 1121 to 1821 1 to 700       700/701
(99 %)
2 diff
(99.8 %id)
N91729 liver and spleen AAGAB.d 1121 to 1407 9 to 295       287/313
(91 %)
1 diff
(99.7 %id)
FN101059 breast carcinoma AAGAB.d 1141 to 1214 1 to 72       72/86
(83 %)
3 diff
(96.6 %id)
BU164409 epithelioid carcinoma, Pancreas AAGAB.d 1160 to 1751 1 to 598       598/777
(76 %)
12 diff
(98.5 %id)
BI087789 cervix AAGAB.d 1169 to 1728 13 to 582       570/947
(60 %)
15 diff
(98.5 %id)
FN074672 breast carcinoma AAGAB.d 1187 to 1300 112 to 3     Submitted on the opposite strand 110/112
(98 %)
0 diff
(100 %id)
BE766957 nervous_tumor AAGAB.d 1216 to 1863 652 to 6       647/652
(99 %)
0 diff
(100 %id)
BG619832 placenta AAGAB.d 1225 to 1713 1 to 490       490/490
(100 %)
4 diff
(99.2 %id)
BX354324 Neuroblastoma Cot 25-normalized AAGAB.d 1253 to 2242 994 to 12       983/1049
(93 %)
0 diff
(100 %id)
CX782689 human embryonic stem cells AAGAB.d 1267 to 2063 1 to 797     Submitted on the opposite strand 797/797
(100 %)
6 diff
(99.3 %id)
BE181165 head_neck AAGAB.d 1272 to 1492 1 to 220       220/223
(98 %)
10 diff
(95.6 %id)
BX385432   AAGAB.d 1274 to 2251 969 to 1       969/980
(98 %)
9 diff
(99.1 %id)
BE868467 adenocarcinoma, colon AAGAB.d 1293 to 1946 1 to 653       653/657
(99 %)
6 diff
(99.1 %id)
BM476738 leiomyosarcoma, uterus AAGAB.d 1362 to 2296 1 to 935       935/1064
(87 %)
52 diff
(95.2 %id)
CB241976 Human Lung Epithelial cells, lung AAGAB.d 1375 to 1981 1 to 609     Submitted on the opposite strand 609/609
(100 %)
15 diff
(97.6 %id)
TI_159706184   AAGAB.d 1425 to 2280 953 to 105   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 849/1013
(83 %)
26 diff
(97.5 %id)
CX782762 human embryonic stem cells AAGAB.d 1438 to 2285 858 to 12   AAA Submitted on the opposite strand 847/847
(100 %)
2 diff
(99.8 %id)
H59181 liver and spleen AAGAB.d 1452 to 1857 1 to 411       411/424
(96 %)
6 diff
(98.6 %id)
BU608496 Human Lung Epithelial cells, lung AAGAB.d 1479 to 2285 823 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 805/805
(100 %)
3 diff
(99.7 %id)
BU618862 Cell Line, Chondrosarcoma AAGAB.d 1481 to 2288 823 to 18       806/823
(97 %)
0 diff
(100 %id)
BF529633 anaplastic oligodendroglioma with 1p/19qloss, brain AAGAB.d 1501 to 2166 1 to 663       663/963
(68 %)
9 diff
(99.1 %id)
AW176269 breast AAGAB.d 1515 to 1982 1 to 467       467/560
(83 %)
7 diff
(98.8 %id)
BU608106 Human Lung Epithelial cells, lung AAGAB.d 1579 to 2287 726 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 710/710
(100 %)
1 diff
(99.9 %id)
CA430118 Cell Line, Chondrosarcoma AAGAB.d 1579 to 2285 726 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 708/708
(100 %)
1 diff
(99.9 %id)
BX373162 Placenta Cot 25-normalized AAGAB.d 1595 to 2273 689 to 8       682/896
(76 %)
0 diff
(100 %id)
TI_149292802   AAGAB.d 1599 to 2285 766 to 79   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 688/689
(99 %)
2 diff
(99.8 %id)
AA147361   AAGAB.d 1604 to 1946 1 to 343   fully sequenced,   343/343
(100 %)
2 diff
(99.5 %id)
BG028614 Bone, osteosarcoma, cell line AAGAB.d 1604 to 2349 1 to 741       741/933
(79 %)
23 diff
(97.6 %id)
BF438850 pooled AAGAB.d 1618 to 1930 113 to 424     Submitted on the opposite strand 312/424
(73 %)
6 diff
(98.6 %id)
BM974861 lung AAGAB.d 1619 to 2285 686 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 668/668
(100 %)
2 diff
(99.8 %id)
CD366536 Alveolar Macrophage, lung AAGAB.d 1645 to 2285 659 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
FN077949 breast carcinoma AAGAB.d 1691 to 1772 83 to 3     Submitted on the opposite strand 81/83
(97 %)
0 diff
(100 %id)
AI887964 carcinoid, lung AAGAB.d 1701 to 2284 584 to 1       584/584
(100 %)
1 diff
(99.9 %id)
BF809678 colon_ins AAGAB.d 1707 to 1879 29 to 202       174/211
(82 %)
9 diff
(95.8 %id)
BX377830 Placenta Cot 25-normalized AAGAB.d 1713 to 2239 529 to 1       529/529
(100 %)
11 diff
(98.0 %id)
W04598 lung AAGAB.d 1754 to 1977 1 to 226       226/226
(100 %)
3 diff
(98.7 %id)
TI_159714519   AAGAB.d 1754 to 2282 612 to 84   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 529/1044
(50 %)
0 diff
(100 %id)
CB306988 Human Lung Epithelial cells, lung AAGAB.d 1754 to 2282 547 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 529/538
(98 %)
0 diff
(100 %id)
DB360782 mammary gland AAGAB.d 1767 to 2284 512 to 1       512/550
(93 %)
14 diff
(97.5 %id)
BF062455 colon, colon tumor, RER+ AAGAB.d 1775 to 2286 512 to 1       512/512
(100 %)
0 diff
(100 %id)
EC581145 Prostate AAGAB.d 1777 to 1885 9 to 117       109/117
(93 %)
11 diff
(90.6 %id)
AI796028 Kidney AAGAB.d 1778 to 2287 511 to 1       511/511
(100 %)
2 diff
(99.7 %id)
EC578216 Prostate AAGAB.d 1783 to 1885 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
EC461733 Prostate AAGAB.d 1785 to 1885 1 to 99       99/99
(100 %)
3 diff
(97.0 %id)
EC504403 Prostate AAGAB.d 1795 to 1899 1 to 104       104/104
(100 %)
1 diff
(99.1 %id)
EC547597 Prostate AAGAB.d 1795 to 1899 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
EC445776 Prostate AAGAB.d 1796 to 1899 1 to 102       102/102
(100 %)
3 diff
(97.1 %id)
AI279720 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus AAGAB.d 1804 to 2280 475 to 2       474/478
(99 %)
0 diff
(100 %id)
EC521289 Prostate AAGAB.d 1805 to 1906 1 to 101       101/102
(99 %)
2 diff
(98.1 %id)
AI376001   AAGAB.d 1806 to 2286 487 to 6       482/487
(98 %)
0 diff
(100 %id)
BF059420 pooled germ cell tumors AAGAB.d 1806 to 2286 481 to 1       481/481
(100 %)
1 diff
(99.8 %id)
AI828332 adenocarcinoma, Pancreas AAGAB.d 1809 to 1940 132 to 1       132/132
(100 %)
0 diff
(100 %id)
AW242126 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus AAGAB.d 1813 to 2286 475 to 2       474/475
(99 %)
0 diff
(100 %id)
BF001414 colon, colon tumor, RER+ AAGAB.d 1826 to 2286 461 to 1       461/461
(100 %)
0 diff
(100 %id)
BX378189 Placenta Cot 25-normalized AAGAB.d 1828 to 2203 424 to 48       377/382
(98 %)
0 diff
(100 %id)
EC465858 Prostate AAGAB.d 1832 to 1936 1 to 104       104/104
(100 %)
1 diff
(99.1 %id)
TI_153991210   AAGAB.d 1833 to 2285 557 to 105   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 453/453
(100 %)
7 diff
(98.5 %id)
AA707826 pineal gland AAGAB.d 1841 to 2285 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
EC448499 Prostate AAGAB.d 1849 to 1947 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
DB513520 testis AAGAB.d 1851 to 2285 1 to 435     Submitted on the opposite strand 435/435
(100 %)
2 diff
(99.6 %id)
DB538653 hippocampus AAGAB.d 1851 to 2287 1 to 437     Submitted on the opposite strand 437/437
(100 %)
8 diff
(98.2 %id)
EC447933 Prostate AAGAB.d 1852 to 1947 1 to 96       96/96
(100 %)
0 diff
(100 %id)
EC462796 Prostate AAGAB.d 1852 to 1947 1 to 94       94/94
(100 %)
2 diff
(97.9 %id)
EC507202 Prostate AAGAB.d 1852 to 1947 1 to 96       96/96
(100 %)
0 diff
(100 %id)
EC511179 Prostate AAGAB.d 1852 to 1947 1 to 96       96/96
(100 %)
0 diff
(100 %id)
EC521371 Prostate AAGAB.d 1852 to 1947 1 to 95       95/95
(100 %)
1 diff
(99.0 %id)
AI758798 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus AAGAB.d 1852 to 1940 89 to 1       89/89
(100 %)
0 diff
(100 %id)
FN124742 breast carcinoma AAGAB.d 1853 to 1908 59 to 5     Submitted on the opposite strand 55/60
(91 %)
0 diff
(100 %id)
W73912 heart AAGAB.d 1856 to 2285 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AI066425 senescent fibroblast AAGAB.d 1857 to 2286 435 to 6       430/435
(98 %)
0 diff
(100 %id)
DB531901 hippocampus AAGAB.d 1858 to 2284 1 to 427     Submitted on the opposite strand 427/428
(99 %)
2 diff
(99.6 %id)
W73913.
matches multiple genes
heart AAGAB.d 1859 to 2285 427 to 1     also hits gene EDAR 427/427
(100 %)
0 diff
(100 %id)
FN102328 breast carcinoma AAGAB.d 1865 to 1934 1 to 69       69/70
(98 %)
3 diff
(95.8 %id)
AI281116 adenocarcinoma, colon AAGAB.d 1867 to 2286 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AA111930   AAGAB.d 1872 to 2299 443 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 428/431
(99 %)
0 diff
(100 %id)
DB534366 hippocampus AAGAB.d 1873 to 2287 1 to 415     Submitted on the opposite strand 415/415
(100 %)
3 diff
(99.3 %id)
AA983585 adenocarcinoma, colon AAGAB.d 1873 to 2286 415 to 2       414/415
(99 %)
0 diff
(100 %id)
AL040453 testis AAGAB.d 1876 to 2299 1 to 424   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 424/424
(100 %)
0 diff
(100 %id)
BU175435 large cell carcinoma, lung AAGAB.d 1876 to 2289 1 to 414       414/1115
(37 %)
2 diff
(99.9 %id)
AI285091 adenocarcinoma, colon AAGAB.d 1881 to 2286 407 to 2       406/407
(99 %)
0 diff
(100 %id)
H59137 liver and spleen AAGAB.d 1882 to 2280 418 to 16       403/418
(96 %)
0 diff
(100 %id)
FN047737 breast carcinoma AAGAB.d 1891 to 1986 1 to 96       96/96
(100 %)
0 diff
(100 %id)
AI825596 pooled germ cell tumors AAGAB.d 1899 to 2286 388 to 1       388/388
(100 %)
0 diff
(100 %id)
AI033830 liver and spleen AAGAB.d 1900 to 2285 387 to 1       387/387
(100 %)
2 diff
(99.5 %id)
AW301179 Kidney AAGAB.d 1902 to 2287 396 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 386/394
(97 %)
1 diff
(99.8 %id)
EC500117 Prostate AAGAB.d 1903 to 1987 8 to 93       86/96
(89 %)
2 diff
(98.0 %id)
FN066842 breast carcinoma AAGAB.d 1907 to 1994 1 to 91       91/97
(93 %)
3 diff
(97.0 %id)
AI910479 colon, colon tumor, RER+ AAGAB.d 1907 to 2286 386 to 7       380/386
(98 %)
0 diff
(100 %id)
EC582101 Prostate AAGAB.d 1909 to 1994 1 to 85       85/91
(93 %)
2 diff
(97.9 %id)
EC532814 Prostate AAGAB.d 1911 to 1994 1 to 83       83/94
(88 %)
2 diff
(97.9 %id)
AV728355 hypothalamus AAGAB.d 1911 to 2285 23 to 397   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 375/397
(94 %)
2 diff
(99.5 %id)
AA147338   AAGAB.d 1916 to 2283 370 to 1   fully sequenced,   370/370
(100 %)
1 diff
(99.8 %id)
EC583015 Prostate AAGAB.d 1919 to 1994 1 to 75       75/85
(88 %)
1 diff
(98.9 %id)
AI160598 placenta AAGAB.d 1920 to 2286 370 to 4       367/370
(99 %)
0 diff
(100 %id)
AI208192   AAGAB.d 1921 to 2286 368 to 3       366/368
(99 %)
0 diff
(100 %id)
AW970509   AAGAB.d 1922 to 2283 362 to 1     Submitted on the opposite strand 362/511
(70 %)
0 diff
(100 %id)
AW016807   AAGAB.d 1927 to 2285 376 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 359/369
(97 %)
1 diff
(99.8 %id)
AW207093   AAGAB.d 1931 to 2285 373 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 355/355
(100 %)
0 diff
(100 %id)
AW589871 pooled germ cell tumors AAGAB.d 1953 to 2286 334 to 1       334/334
(100 %)
1 diff
(99.8 %id)
AW512748 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors AAGAB.d 1954 to 2286 337 to 5       333/337
(98 %)
0 diff
(100 %id)
AW780418 colon, moderately-differentiated adenocarcinoma AAGAB.d 1954 to 2299 346 to 1       346/346
(100 %)
1 diff
(99.8 %id)
AA988692 Kidney, kidney tumor AAGAB.d 1958 to 2285 327 to 1       327/327
(100 %)
2 diff
(99.4 %id)
AW137387   AAGAB.d 1960 to 2288 345 to 17       329/345
(95 %)
0 diff
(100 %id)
AA551994 colon AAGAB.d 1963 to 2284 322 to 1       322/322
(100 %)
0 diff
(100 %id)
AA975620 Kidney, kidney tumor AAGAB.d 1976 to 2285 332 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 310/310
(100 %)
4 diff
(98.8 %id)
AI767833 2 pooled tumors (clear cell type), Kidney AAGAB.d 1977 to 2285 338 to 29   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 310/311
(99 %)
14 diff
(95.5 %id)
N64714 liver and spleen AAGAB.d 1994 to 2300 311 to 2       310/316
(98 %)
0 diff
(100 %id)
AW198035 adenocarcinoma, Pancreas AAGAB.d 1998 to 2291 296 to 2       295/296
(99 %)
0 diff
(100 %id)
DB525148 testis AAGAB.d 2012 to 2285 1 to 275     Submitted on the opposite strand 275/275
(100 %)
3 diff
(99.0 %id)
D20263   AAGAB.d 2025 to 2271 1 to 247     Submitted on the opposite strand 247/247
(100 %)
1 diff
(99.6 %id)
D82491   AAGAB.d 2032 to 2497 1 to 465       465/465
(100 %)
5 diff
(99.0 %id)
AW339377 carcinoid, lung AAGAB.d 2040 to 2284 245 to 1       245/245
(100 %)
4 diff
(98.4 %id)
AA857846 adenocarcinoma, colon AAGAB.d 2076 to 2283 225 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 208/208
(100 %)
0 diff
(100 %id)
BM714842 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2090 to 2726 1 to 637       637/637
(100 %)
1 diff
(99.9 %id)
EC462987 Prostate AAGAB.d 2100 to 2220 1 to 122       122/122
(100 %)
2 diff
(98.4 %id)
EC470353 Prostate AAGAB.d 2101 to 2220 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
TI_154062047   AAGAB.d 2103 to 2908 898 to 104   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 795/964
(82 %)
17 diff
(98.3 %id)
F13806   AAGAB.d 2106 to 2285 186 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 176/176
(100 %)
3 diff
(98.3 %id)
AW970488   AAGAB.d 2107 to 2709 1 to 596       596/598
(99 %)
16 diff
(97.4 %id)
W19642 parathyroid gland, parathyroid tumor AAGAB.d 2108 to 2622 1 to 528       528/528
(100 %)
19 diff
(96.5 %id)
BM714758 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2112 to 2709 1 to 599   fully sequenced, Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 599/599
(100 %)
1 diff
(99.9 %id)
FN117263 breast carcinoma AAGAB.d 2164 to 2283 1 to 122       122/132
(92 %)
4 diff
(97.0 %id)
CF264678 Brain glioblastoma AAGAB.d 2195 to 2925 776 to 40   AAA Submitted on the opposite strand 737/876
(84 %)
0 diff
(100 %id)
CA420967 Bone, Enchondroma cell line AAGAB.d 2217 to 2908 709 to 19   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 691/691
(100 %)
3 diff
(99.6 %id)
CA312633 Human Lung Epithelial cells, lung AAGAB.d 2242 to 2925 702 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 684/684
(100 %)
0 diff
(100 %id)
CA424764 cell lines, Chondrosarcoma AAGAB.d 2247 to 2927 696 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 680/680
(100 %)
2 diff
(99.8 %id)
BF754091 colon AAGAB.d 2250 to 2387 1 to 138       138/144
(95 %)
2 diff
(98.7 %id)
BU740938 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2345 to 2927 599 to 18   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 582/582
(100 %)
3 diff
(99.5 %id)
AI760531 B-cell, chronic lymphotic leukemia AAGAB.d 2385 to 2927 545 to 1       545/545
(100 %)
7 diff
(98.8 %id)
BU739731 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2387 to 2927 558 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 542/542
(100 %)
2 diff
(99.7 %id)
AA843936 parathyroid gland, parathyroid tumor AAGAB.d 2397 to 2912 517 to 1       517/517
(100 %)
4 diff
(99.3 %id)
AI150416   AAGAB.d 2401 to 2770 369 to 1       369/369
(100 %)
1 diff
(99.8 %id)
BF591108 colon, colon tumor, RER+ AAGAB.d 2402 to 2930 529 to 8       522/529
(98 %)
0 diff
(100 %id)
AI888660 poorly differentiated adenocarcinoma withsignet ring cell features, stomach AAGAB.d 2480 to 2929 453 to 1       453/453
(100 %)
3 diff
(99.4 %id)
AA541260 colon AAGAB.d 2502 to 2927 419 to 1       419/419
(100 %)
4 diff
(99.1 %id)
AA890367 parathyroid gland, parathyroid tumor AAGAB.d 2527 to 2912 387 to 1       387/387
(100 %)
4 diff
(99.0 %id)
BU739420 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2529 to 2927 416 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 400/400
(100 %)
2 diff
(99.5 %id)
BF718267 epidermis, skin AAGAB.d 2578 to 2766 189 to 2       188/189
(99 %)
0 diff
(100 %id)
AI702602 pooled AAGAB.d 2585 to 2930 345 to 1       345/345
(100 %)
3 diff
(99.2 %id)
AI335790 uterus AAGAB.d 2616 to 2927 306 to 1       306/306
(100 %)
7 diff
(97.8 %id)
BU608277 Human Lung Epithelial cells, lung AAGAB.d 2645 to 2930 297 to 16       282/326
(86 %)
0 diff
(100 %id)
CA312635 Human Lung Epithelial cells, lung AAGAB.d 2650 to 2927 297 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 281/314
(89 %)
4 diff
(98.8 %id)
BM969821 lung, Primary Lung Epithelial Cells AAGAB.d 2653 to 2927 291 to 17   AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 275/301
(91 %)
0 diff
(100 %id)
AA926889 pooled AAGAB.d 2654 to 2927 274 to 1       274/277
(98 %)
0 diff
(100 %id)
AI478428 Kidney AAGAB.d 2658 to 2927 270 to 1       270/270
(100 %)
0 diff
(100 %id)
BE671427 carcinoid, lung AAGAB.d 2666 to 3046 1 to 381   tiling clone, Submitted on the opposite strand 381/381
(100 %)
1 diff
(99.8 %id)
T16376   AAGAB.d 2672 to 2927 256 to 1       256/256
(100 %)
1 diff
(99.7 %id)
BU739383 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid AAGAB.d 2679 to 2927 266 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (14/14 A in genome downstream of last aligned base) 250/250
(100 %)
1 diff
(99.6 %id)
N89887 parathyroid gland, parathyroid tumor AAGAB.d 2770 to 2906 137 to 1       137/137
(100 %)
0 diff
(100 %id)
DC329601 corpus callosum AAGAB.e 1 to 539 1 to 539   tiling clone,   539/539
(100 %)
0 diff
(100 %id)
DC315715 amygdala AAGAB.e 58 to 621 1 to 564       564/564
(100 %)
0 diff
(100 %id)
AK294402 amygdala AAGAB.e 61 to 1075 1 to 1015   tiling clone,   1015/1015
(100 %)
0 diff
(100 %id)
DC316696 amygdala AAGAB.e 61 to 627 1 to 567       567/567
(100 %)
0 diff
(100 %id)
DA364425 subthalamic nucleus AAGAB.e 95 to 664 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
DA165618 amygdala AAGAB.e 96 to 678 2 to 584   capped   583/583
(100 %)
1 diff
(99.9 %id)
DA155503 amygdala AAGAB.e 98 to 664 2 to 569   capped   568/569
(99 %)
1 diff
(99.9 %id)
BG534496 lung AAGAB.f 1 to 807 3 to 799 W181C T182D I184D F185I K186Q ... tiling clone,   799/802
(99 %)
33 diff
(95.9 %id)
GD139009   AAGAB.f 690 to 821 1 to 132   tiling clone,   132/133
(99 %)
5 diff
(96.3 %id)
AL832256 lymph node AAGAB.g 1 to 1782 1 to 1781 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1781/1781
(100 %)
7 diff
(99.7 %id)
BJ993196 hepatoblastoma AAGAB.h-u 1 to 349 349 to 1   tiling clone,   349/349
(100 %)
0 diff
(100 %id)
AK126986 brain AAGAB.h-u 210 to 3960 1 to 3751 W38* tiling clone, available from FLJ,   3751/3751
(100 %)
5 diff
(99.9 %id)
DA226688 brain AAGAB.h-u 211 to 770 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
BX648272 fetal kidney AAGAB.h-u 2008 to 6185 1 to 4178   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 4178/4178
(100 %)
6 diff
(99.9 %id)
AA417755 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus AAGAB.h-u 3059 to 3583 1 to 525       525/525
(100 %)
3 diff
(99.5 %id)
BE168283 head_neck AAGAB.h-u 3277 to 3652 384 to 11     Submitted on the opposite strand 374/384
(97 %)
0 diff
(100 %id)
DB305242 brain AAGAB.h-u 3429 to 3960 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
AW272170 Kidney AAGAB.h-u 3450 to 3958 511 to 2       510/511
(99 %)
0 diff
(100 %id)
AI610673 poorly differentiated adenocarcinoma withsignet ring cell features, stomach AAGAB.h-u 3536 to 3961 426 to 1       426/426
(100 %)
0 diff
(100 %id)
AA832285 germinal center B cell AAGAB.h-u 3598 to 3967 370 to 1       370/370
(100 %)
0 diff
(100 %id)
DA251200 caudate nucleus AAGAB.h-u 4237 to 4779 2 to 545   capped   544/544
(100 %)
3 diff
(99.5 %id)
BG741203 skin AAGAB.h-u 4304 to 5147 1 to 841       841/849
(99 %)
31 diff
(96.4 %id)
R20230 whole brain AAGAB.h-u 4495 to 4907 1 to 430   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 430/432
(99 %)
20 diff
(95.4 %id)
R43323 whole brain AAGAB.h-u 6555 to 6827 288 to 12   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 277/286
(96 %)
5 diff
(98.3 %id)
BU790558 Pancreas, Purified pancreatic islet AAGAB.i-u 1 to 401 1 to 401   tiling clone, fully sequenced,   401/401
(100 %)
3 diff
(99.3 %id)
BU790261 Pancreas, Purified pancreatic islet AAGAB.i-u 371 to 936 566 to 1 exact tiling clone, fully sequenced,   566/566
(100 %)
0 diff
(100 %id)
CN282683 embryonic stem cells, cell lines H1, H7, andH9 AAGAB.i-u 426 to 1045 1 to 621 exact     621/621
(100 %)
2 diff
(99.7 %id)
DA412795 thalamus AAGAB.i-u 807 to 1367 2 to 562   tiling clone, capped   561/561
(100 %)
1 diff
(99.9 %id)
AW051139 serous papillary carcinoma, high grade, 2pooled tumors, uterus AAGAB.j-u 1 to 304 303 to 1   tiling clone,   303/303
(100 %)
2 diff
(99.4 %id)
AL713485 human skeletal muscle AAGAB.j-u 244 to 853 41 to 651   tiling clone,   611/651
(93 %)
6 diff
(99.1 %id)
DA988588 synovial membrane tissue from rheumatioidarthritis AAGAB.k 1 to 562 2 to 563 I23L tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA146548 amygdala AAGAB.l 1 to 529 2 to 530 exact tiling clone, capped   529/529
(100 %)
0 diff
(100 %id)
DB312647 thalamus AAGAB.m-u 1 to 463 463 to 1 I4X tiling clone,   463/465
(99 %)
1 diff
(99.8 %id)
AI760601 colon, colon tumor, RER+ Gene AAGAB, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i-u, .j-u, .k, .l, .m-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI